SINAPPS stands for Study of Immunology in Antibody Positive Psychosis. We are a research group formed of collaborating Universities in the UK, investigating the role of autoimmune antibodies as a cause of psychosis.
SINAPPS2 TRIAL MANAGEMENT GROUP
Professor Alasdair Coles Chief Investigator and Principal Investigator, University of Cambridge
Professor Belinda Lennox Principal investigator, University of Oxford
Professor Eileen Joyce, Co-investigator, University College London
Dr Michael Zandi , Principal Investigator, UCL Hospitals NHS Trust, London
SINAPPS2 Trial PRINCIPAL Investigators
Dr Akram Hosseini, Queen's Medical Centre, Nottingham